CCDC17
geneOn this page
Also known as FLJ33084
Summary
CCDC17 (coiled-coil domain containing 17, HGNC:26574) is a protein-coding gene on chromosome 1p34.1, encoding Coiled-coil domain-containing protein 17 (Q96LX7).
Implicated in colorectal adenocarcinoma.
Source: NCBI Gene 149483 — RefSeq curated summary.
At a glance
- GWAS associations: 15
- Clinical variants (ClinVar): 137 total
- MANE Select transcript:
NM_001114938
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26574 |
| Approved symbol | CCDC17 |
| Name | coiled-coil domain containing 17 |
| Location | 1p34.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ33084 |
| Ensembl gene | ENSG00000159588 |
| Ensembl biotype | protein_coding |
| Entrez | 149483 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 7 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000372044, ENST00000421127, ENST00000445048, ENST00000464739, ENST00000479529, ENST00000482416, ENST00000491755, ENST00000525599, ENST00000528266, ENST00000865268, ENST00000865269, ENST00000865270, ENST00000865271
RefSeq mRNA: 2 — MANE Select: NM_001114938
NM_001114938, NM_001190182
CCDS: CCDS44131, CCDS53314
Canonical transcript exons
ENST00000528266 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001064988 | 45623217 | 45623439 |
| ENSE00001687587 | 45623557 | 45623652 |
| ENSE00002158280 | 45620044 | 45620433 |
| ENSE00003476098 | 45622751 | 45622834 |
| ENSE00003556952 | 45621877 | 45621995 |
| ENSE00003581538 | 45620723 | 45620833 |
| ENSE00003611925 | 45621281 | 45621484 |
| ENSE00003624502 | 45622549 | 45622667 |
| ENSE00003633118 | 45620903 | 45621113 |
| ENSE00003647139 | 45622955 | 45623117 |
| ENSE00003689373 | 45621638 | 45621735 |
| ENSE00003691528 | 45622241 | 45622348 |
| ENSE00003843908 | 45623736 | 45624054 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 99.53.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1706 / max 43.7622, expressed in 36 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 12143 | 0.1484 | 36 |
| 12142 | 0.0223 | 10 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 99.53 | gold quality |
| bronchial epithelial cell | CL:0002328 | 98.72 | gold quality |
| bronchus | UBERON:0002185 | 97.87 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.73 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 93.64 | gold quality |
| oviduct epithelium | UBERON:0004804 | 92.97 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 91.37 | gold quality |
| fallopian tube | UBERON:0003889 | 90.33 | gold quality |
| right lung | UBERON:0002167 | 81.14 | gold quality |
| left uterine tube | UBERON:0001303 | 81.01 | gold quality |
| trachea | UBERON:0003126 | 80.40 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 80.28 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 79.98 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 79.17 | gold quality |
| ileal mucosa | UBERON:0000331 | 77.69 | silver quality |
| caput epididymis | UBERON:0004358 | 77.48 | gold quality |
| endocervix | UBERON:0000458 | 77.08 | gold quality |
| right lobe of liver | UBERON:0001114 | 76.69 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 74.53 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 74.27 | gold quality |
| tibialis anterior | UBERON:0001385 | 73.81 | silver quality |
| gastrocnemius | UBERON:0001388 | 73.74 | gold quality |
| kidney epithelium | UBERON:0004819 | 73.36 | gold quality |
| granulocyte | CL:0000094 | 73.12 | gold quality |
| muscle of leg | UBERON:0001383 | 72.76 | gold quality |
| upper lobe of lung | UBERON:0008948 | 72.19 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 71.98 | gold quality |
| apex of heart | UBERON:0002098 | 71.53 | gold quality |
| pancreatic ductal cell | CL:0002079 | 71.37 | silver quality |
| blood | UBERON:0000178 | 71.06 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 558.13 |
| E-HCAD-1 | yes | 25.80 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ccdc17 | ENSMUSG00000034035 |
| rattus_norvegicus | Ccdc17 | ENSRNOG00000023216 |
Protein
Protein identifiers
Coiled-coil domain-containing protein 17 — Q96LX7 (reviewed: Q96LX7)
All UniProt accessions (3): Q96LX7, F2Z395, F8W7G4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell projection. Cilium. Cytoplasm. Cytoskeleton. Cilium axoneme.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96LX7-4 | 1 | yes |
| Q96LX7-5 | 2 | |
| Q96LX7-2 | 3 | |
| Q96LX7-3 | 4 |
RefSeq proteins (2): NP_001108410, NP_001177111 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038800 | CCDC17 | Family |
UniProt features (23 total): sequence conflict 8, sequence variant 4, splice variant 3, coiled-coil region 3, region of interest 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LX7-F1 | 68.58 | 0.28 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 41 (showing top):
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, chr1p34, GOCC_CYTOPLASMIC_REGION, GOCC_CILIUM, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MEISSNER_NPC_HCP_WITH_H3K4ME2, SETD7_TARGET_GENES, ZNF708_TARGET_GENES, GSE13229_IMM_VS_MATURE_NKCELL_DN, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP, MANNO_MIDBRAIN_NEUROTYPES_HPERIC, MANNO_MIDBRAIN_NEUROTYPES_HMGL, MANNO_MIDBRAIN_NEUROTYPES_HRGL2B, MANNO_MIDBRAIN_NEUROTYPES_HRGL2A
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cilium (GO:0005929), axoneme (GO:0005930)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1224 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC17 | ZNF684 | Q5T5D7 | 628 |
| CCDC17 | PHETA1 | Q8N4B1 | 541 |
| CCDC17 | CFAP210 | Q0VFZ6 | 533 |
| CCDC17 | CFAP77 | Q6ZQR2 | 507 |
| CCDC17 | GPBP1L1 | Q9HC44 | 456 |
| CCDC17 | SPACA9 | Q96E40 | 447 |
| CCDC17 | CFAP61 | Q8NHU2 | 410 |
| CCDC17 | HIVEP1 | P15822 | 400 |
| CCDC17 | BRINP3 | Q76B58 | 395 |
| CCDC17 | AKR1A1 | P14550 | 388 |
| CCDC17 | ERICH3 | Q5RHP9 | 384 |
| CCDC17 | CCDC181 | Q5TID7 | 359 |
| CCDC17 | RNF167 | Q9H6Y7 | 357 |
| CCDC17 | ANKRA2 | Q9H9E1 | 355 |
| CCDC17 | ERGIC2 | Q96RQ1 | 349 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GOLGA2 | CCDC17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT31 | CCDC17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | CCDC17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC17 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC17 | KRT31 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC17 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| purT | CCDC17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FGFR3 | CCDC17 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (14): CCDC17 (Two-hybrid), CCDC17 (Two-hybrid), CCDC17 (Two-hybrid), CCDC17 (Two-hybrid), CCDC17 (Two-hybrid), CCDC17 (Two-hybrid), KRTAP8-1 (Two-hybrid), KRT16 (Two-hybrid), KRTAP6-2 (Two-hybrid), KRTAP19-5 (Two-hybrid), CCDC17 (Two-hybrid), CCDC17 (Protein-peptide), CCDC17 (Affinity Capture-MS), CCDC17 (Protein-peptide)
ESM2 similar proteins: A1L3T7, D4A929, O15049, O94812, P0C7N4, P58660, P97680, Q17Q97, Q1LU99, Q3LUD3, Q3UPH7, Q3UYR4, Q400C9, Q4FZU8, Q562E7, Q571B6, Q58EX7, Q5EB20, Q5JYT7, Q5ND29, Q5ND34, Q5PQS0, Q5XIS1, Q68FE6, Q6PGG2, Q6ZQ12, Q6ZVH7, Q7TNF8, Q7TSI1, Q7Z3H0, Q80U16, Q8BWG4, Q8BXP5, Q8BYG0, Q8C7U1, Q8CB62, Q8CE13, Q8K1S6, Q8K330, Q8N137
Diamond homologs: Q8CE13, Q96LX7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
137 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 115 |
| Likely benign | 5 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1660 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:45621878:T:TA | donor_gain | 1.0000 |
| 1:45623229:G:C | donor_gain | 1.0000 |
| 1:45620431:CAC:C | acceptor_gain | 0.9900 |
| 1:45620433:CCTGT:C | acceptor_loss | 0.9900 |
| 1:45620434:C:T | acceptor_loss | 0.9900 |
| 1:45620435:T:A | acceptor_loss | 0.9900 |
| 1:45620704:G:C | donor_gain | 0.9900 |
| 1:45620736:TGG:T | donor_gain | 0.9900 |
| 1:45620743:CATGG:C | donor_gain | 0.9900 |
| 1:45620744:A:AC | donor_gain | 0.9900 |
| 1:45620744:ATGGA:A | donor_gain | 0.9900 |
| 1:45620754:G:A | donor_gain | 0.9900 |
| 1:45621382:T:TA | donor_gain | 0.9900 |
| 1:45621874:AACCT:A | donor_gain | 0.9900 |
| 1:45621875:A:C | donor_gain | 0.9900 |
| 1:45621882:AGAAG:A | donor_gain | 0.9900 |
| 1:45621912:C:CT | donor_gain | 0.9900 |
| 1:45621913:C:CT | donor_gain | 0.9900 |
| 1:45621947:C:A | donor_gain | 0.9900 |
| 1:45622539:T:TA | donor_gain | 0.9900 |
| 1:45622853:C:CT | acceptor_gain | 0.9900 |
| 1:45622953:AC:A | donor_gain | 0.9900 |
| 1:45622954:CC:C | donor_gain | 0.9900 |
| 1:45623027:G:C | donor_gain | 0.9900 |
| 1:45623252:T:TA | donor_gain | 0.9900 |
| 1:45620734:A:AC | donor_gain | 0.9800 |
| 1:45620735:C:CC | donor_gain | 0.9800 |
| 1:45620735:CTG:C | donor_gain | 0.9800 |
| 1:45621579:C:CA | donor_gain | 0.9800 |
| 1:45621583:TA:T | donor_gain | 0.9800 |
AlphaMissense
3924 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:45623850:G:C | F20L | 0.982 |
| 1:45623850:G:T | F20L | 0.982 |
| 1:45623852:A:G | F20L | 0.982 |
| 1:45621005:A:C | F499L | 0.980 |
| 1:45621005:A:T | F499L | 0.980 |
| 1:45621007:A:G | F499L | 0.980 |
| 1:45621461:T:A | D403V | 0.979 |
| 1:45621461:T:G | D403A | 0.974 |
| 1:45621462:C:G | D403H | 0.972 |
| 1:45620740:A:G | Y565H | 0.971 |
| 1:45620813:A:C | F540L | 0.969 |
| 1:45620813:A:T | F540L | 0.969 |
| 1:45620815:A:G | F540L | 0.969 |
| 1:45623851:A:G | F20S | 0.967 |
| 1:45621461:T:C | D403G | 0.966 |
| 1:45621466:G:C | F401L | 0.965 |
| 1:45621466:G:T | F401L | 0.965 |
| 1:45621468:A:G | F401L | 0.965 |
| 1:45621455:A:G | L405P | 0.964 |
| 1:45621460:A:C | D403E | 0.961 |
| 1:45621460:A:T | D403E | 0.961 |
| 1:45621311:G:T | A453D | 0.960 |
| 1:45621457:G:C | F404L | 0.960 |
| 1:45621457:G:T | F404L | 0.960 |
| 1:45621459:A:G | F404L | 0.960 |
| 1:45620817:A:T | L539H | 0.959 |
| 1:45621462:C:A | D403Y | 0.958 |
| 1:45620974:A:G | W510R | 0.954 |
| 1:45620974:A:T | W510R | 0.954 |
| 1:45621006:A:C | F499C | 0.951 |
dbSNP variants (sampled 300 via entrez): RS1001030214 (1:45624752 G>A,C), RS1001558243 (1:45622527 G>C), RS1001630531 (1:45622300 T>A), RS1002172613 (1:45624973 T>A,C,G), RS1002360319 (1:45619785 G>A), RS1002369153 (1:45625242 C>G,T), RS1003207074 (1:45619567 C>T), RS1003682234 (1:45622694 T>A,C), RS1003868041 (1:45624375 G>A), RS1004632363 (1:45621487 G>C), RS1005676738 (1:45625284 T>C), RS1005726102 (1:45624021 C>A,T), RS1005764293 (1:45620117 C>T), RS1006680714 (1:45622579 G>A), RS1006879129 (1:45620682 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
15 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004571_30 | Iron status biomarkers (total iron binding capacity) | 8.000000e-07 |
| GCST004572_19 | Iron status biomarkers (transferrin saturation) | 8.000000e-07 |
| GCST004604_13 | Hematocrit | 3.000000e-14 |
| GCST005951_37 | Body mass index | 8.000000e-10 |
| GCST008839_147 | Height | 2.000000e-13 |
| GCST010241_256 | Apolipoprotein A1 levels | 5.000000e-08 |
| GCST010696_7 | Cortical thickness (min-P) | 3.000000e-08 |
| GCST010697_28 | Cortical surface area (min-P) | 2.000000e-08 |
| GCST010698_30 | Subcortical volume (min-P) | 3.000000e-08 |
| GCST010699_45 | Brain morphology (min-P) | 3.000000e-08 |
| GCST010700_23 | Cortical thickness (MOSTest) | 1.000000e-10 |
| GCST010701_9 | Cortical surface area (MOSTest) | 2.000000e-08 |
| GCST010702_139 | Subcortical volume (MOSTest) | 4.000000e-14 |
| GCST010703_258 | Brain morphology (MOSTest) | 2.000000e-13 |
| GCST012442_1 | Age-related hearing impairment | 1.000000e-09 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006334 | total iron binding capacity |
| EFO:0004348 | hematocrit |
| EFO:0004340 | body mass index |
| EFO:0004614 | apolipoprotein A 1 measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | increases expression, increases methylation | 3 |
| Air Pollutants | increases abundance, increases expression, affects expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bufotalin | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| pentanal | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| clothianidin | decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Amiodarone | increases expression | 1 |
| Atrazine | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Ozone | increases abundance, affects expression | 1 |
| Quercetin | increases expression | 1 |
| Testosterone | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): presbycusis